Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04561453 |
|
Recruitment Status :
Recruiting
First Posted : September 23, 2020
Last Update Posted : February 20, 2024
|
Sponsor:
University of Washington
Collaborators:
Natera, Inc.
SEngine Precision Medicine, Inc.
Information provided by (Responsible Party):
University of Washington
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | July 31, 2024 |
| Estimated Study Completion Date : | July 1, 2025 |